Results 191 to 200 of about 60,894 (286)

Antibody Response to a Seven-Valent Pneumococcal Conjugated Vaccine in Patients with Ataxia-Telangiectasia [PDF]

, 2004
Özden Sanal, Fügen Ersoy, İlhan Tezcan, Ayşe Metìn, Tuba Turul, S. Gariboglu, Leman Yel   +6 more
openalex   +1 more source

Delayed Transition to 20-Valent Pneumococcal Conjugate Vaccine in Pediatric National Immunization Programs: Forgone Public Health and Economic Benefit. [PDF]

Infect Dis Ther
Perdrizet J, Ta A, Huang L, Wannaadisai W, Ilic A, Hayford K, Sabra A.   +6 more
europepmc   +1 more source

Intranasal Immunization with Pneumococcal Conjugate Vaccines with LT-K63, a Nontoxic Mutant of Heat-Labile Enterotoxin, as Adjuvant Rapidly Induces Protective Immunity against Lethal Pneumococcal Infections in Neonatal Mice

, 2002
Håvard Jakobsen, Stefanía P. Bjarnarson, Giuseppe Del Giudice, Monique Moreau, Claire‐Anne Siegrist, Ingileif Jónsdóttir   +5 more
openalex   +1 more source

What can children gain from pneumococcal conjugate vaccines? [PDF]

, 2004
Heikki Peltola, Robert Booy, Heinz‐Josef Schmitt   +2 more
openalex   +1 more source

Immunogenicity of yellow fever vaccine co-administered with 13-valent pneumococcal conjugate vaccine in rural Gambia: A cluster-randomised trial. [PDF]

Vaccine
Osei I, Schmidt-Chanasit J, Licciardi PV, Secka O, D'Alessandro U, Salaudeen R, Sarwar G, Clarke E, Mohammed NI, Nguyen C, Greenwood B, Jansen S, Mackenzie GA.   +12 more
europepmc   +1 more source

Similar Antibody Concentrations in Filipino Infants at Age 9 Months, after 1 or 3 Doses of an Adjuvanted, 11‐Valent Pneumococcal Diphtheria/Tetanus–Conjugated Vaccine: A Randomized Controlled Trial [PDF]

, 2004
Marilla Lucero, Taneli Puumalainen, Juanita M. Ugpo, Gail Williams, Helena Käyhty, Hanna Nohynek   +5 more
openalex   +1 more source

Correction to: Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. [PDF]

Open Forum Infect Dis
europepmc   +1 more source

Cost-Effectiveness Analysis of the Use of V116, a 21-Valent Pneumococcal Conjugate Vaccine, in Vaccine-Naïve Adults Aged ≥ 65 Years in the United States. [PDF]

Infect Dis Ther
Yi Z, Owusu-Edusei K, Elbasha E.
europepmc   +1 more source

PIN15 PREFERENCES AND WILLINGNESS-TO-PAY FOR HEALTH STATES PREVENTED BY PNEUMOCOCCAL CONJUGATE VACCINE

, 2002
LA Prosser, MA O’Brien, GT Ray, JM Santoli, TA Lieu   +4 more
openalex   +1 more source

Effect of 10-valent pneumococcal conjugate vaccine on trends of pneumococcal meningitis in children under five years, Uganda, 2003-2022. [PDF]

BMC Infect Dis
Nuwamanya Y, Ampeire I, Baganizi M, Atugonza R, Nsubuga F, Kwesiga B, Migisha R, Bulage L, Kadobera D, Ario AR, Kisakye A.   +10 more
europepmc   +1 more source